{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:29:03Z","timestamp":1761647343200},"reference-count":106,"publisher":"Oxford University Press (OUP)","issue":"955","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>There are many aspects to the management of epilepsy in women related to their role in reproduction. Some of these need to be considered in adolescents, some are related to pregnancy, concerning both the mother and her infant, and others with the menstrual cycle and the menopause. This review considers contraception, fertility, teratogenicity, and the use of folic acid. It also discusses the special investigations in pregnancy, hyperemesis, the effect of pregnancy on the control of epilepsy, the effect of seizures on the fetus, a first fit in pregnancy, pseudoseizures, seizures during delivery, vitamin K, breast feeding, postpartum maternal epilepsy, hereditary risks, counselling, catamenial epilepsy, the menopause, and bone density.<\/jats:p>","DOI":"10.1136\/pgmj.2004.030221","type":"journal-article","created":{"date-parts":[[2005,5,5]],"date-time":"2005-05-05T17:48:14Z","timestamp":1115315294000},"page":"278-285","source":"Crossref","is-referenced-by-count":28,"title":["Management of epilepsy in women"],"prefix":"10.1093","volume":"81","author":[{"given":"M D","family":"O\u2019Brien","sequence":"first","affiliation":[{"name":"Department of Neurology, Guy\u2019s Hospital , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S K","family":"Gilmour-White","sequence":"additional","affiliation":[{"name":"Department of Neurology, Guy\u2019s Hospital , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,5,5]]},"reference":[{"key":"2023042408274943300_R1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/seiz.1999.0295","article-title":"Best practice guidelines for the management women with epilepsy","volume":"8","author":"Crawford","year":"1999","journal-title":"Seizure"},{"key":"2023042408274943300_R2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/seiz.1999.0274","article-title":"Gender difference in management of epilepsy\u2014what women are hearing","volume":"8","author":"Crawford","year":"1999","journal-title":"Seizure"},{"key":"2023042408274943300_R3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1528-1157.2002.13001.x","article-title":"The importance of drug interactions in epilepsy therapy","volume":"43","author":"Patsalos","year":"2002","journal-title":"Epilepsia"},{"key":"2023042408274943300_R4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1528-1157.2000.tb02174.x","article-title":"Clinical pharmacology of topiramate: a review","volume":"41","author":"Garnett","year":"2000","journal-title":"Epilepsia"},{"key":"2023042408274943300_R5","first-page":"122","volume-title":"Contraception: your questions answered","author":"Guillebaud","year":"2004","edition":"4th"},{"key":"2023042408274943300_R6","first-page":"128","volume-title":"Contraception: your questions answered","author":"Guillebaud","year":"2004","edition":"4th"},{"key":"2023042408274943300_R7","first-page":"195","volume-title":"Contraception: your questions answered","author":"Guillebaud","year":"2004","edition":"4th"},{"key":"2023042408274943300_R8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1528-1157.1996.tb06037.x","article-title":"The new antiepileptic drugs and women: efficacy, reproductive health, pregnancy and fetal outcome","volume":"37","author":"Morrell","year":"1996","journal-title":"Epilepsia"},{"key":"2023042408274943300_R9","first-page":"130","volume-title":"Contraception: your questions answered","author":"Guillebaud","year":"2004","edition":"4th"},{"key":"2023042408274943300_R10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-1211(01)00305-9","article-title":"Lamotrigine plasma levels reduced by oral contraceptives","volume":"47","author":"Sabers","year":"2001","journal-title":"Epilepsy Res"},{"key":"2023042408274943300_R11","first-page":"47","article-title":"Lamotrigine plasma levels reduced by oral contraceptives","volume":"43","author":"Sabers","year":"2002","journal-title":"Epilepsia"},{"key":"2023042408274943300_R12","first-page":"294","volume-title":"Contraception: your questions answered","author":"Guillebaud","year":"2004","edition":"4th"},{"key":"2023042408274943300_R13"},{"key":"2023042408274943300_R14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1210\/jcem-48-5-816","article-title":"In vivo metabolism of progestins","volume":"48","author":"Gupta","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042408274943300_R15","first-page":"349","volume-title":"Contraception: your questions answered","author":"Guillebaud","year":"2004","edition":"4th"},{"key":"2023042408274943300_R16","first-page":"472","volume-title":"Contraception: your questions answered","author":"Guillebaud","year":"2004","edition":"4th"},{"key":"2023042408274943300_R17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1783\/147118902101195992","article-title":"Observational series on women using contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs","volume":"28","author":"Bounds","year":"2002","journal-title":"J Fam Plann Reprod Health Care"},{"key":"2023042408274943300_R18","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/S0140-6736(98)04512-7","article-title":"Age specific incidence and prevalence of treated epilepsy in an unselected population of 2,052,922 and age specific fertility rates of women with epilepsy","volume":"352","author":"Wallace","year":"1998","journal-title":"Lancet"},{"key":"2023042408274943300_R19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1525-5050(03)00121-5","article-title":"Relationship of sexual dysfunction to epilepsy laterality and reproductive hormone levels in women","volume":"4","author":"Herzog","year":"2003","journal-title":"Epilepsy Behav"},{"key":"2023042408274943300_R20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1528-1157.1995.tb01009.x","article-title":"Ovulatory function in epilepsy","volume":"36","author":"Cummings","year":"1995","journal-title":"Epilepsia"},{"key":"2023042408274943300_R21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1468-1331.1998.510083.x","article-title":"Seizure occurrence during ovulatory and anovulatory cycles in patients with temporal lobe epilepsy","volume":"5","author":"Bauer","year":"1998","journal-title":"Eur J Neurol"},{"key":"2023042408274943300_R22","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.10391","article-title":"Predictors of ovulatory failure in women with epilepsy","volume":"52","author":"Morrell","year":"2002","journal-title":"Ann Neurol"},{"key":"2023042408274943300_R23","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM199311043291904","article-title":"Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy","volume":"329","author":"Isojarvi","year":"1993","journal-title":"N Engl J Med"},{"key":"2023042408274943300_R24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410430406","article-title":"Valproate, lamotrigine and insulin mediated risks in women with epilepsy","volume":"43","author":"Isojarvi","year":"1998","journal-title":"Ann Neurol"},{"key":"2023042408274943300_R25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1528-1157.2001.28899.x","article-title":"On the association between valproate and polycystic ovary syndrome","volume":"42","author":"Genton","year":"2001","journal-title":"Epilepsia"},{"key":"2023042408274943300_R26","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2165\/00003495-200363120-00002","article-title":"Polycystic ovary syndrome and epilepsy: a review of the evidence","volume":"63","author":"Meo","year":"2003","journal-title":"Drugs"},{"key":"2023042408274943300_R27","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1212\/WNL.61.6_suppl_2.S27","article-title":"Reproductive dysfunction in women with epilepsy","volume":"61","author":"Isojarvi","year":"2003","journal-title":"Neurology"},{"key":"2023042408274943300_R28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jnnp.73.2.121","article-title":"Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management","volume":"73","author":"Bauer","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042408274943300_R29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00002018-200427030-00004","article-title":"Malformation rates in children of women with untreated epilepsy: a meta analysis","volume":"27","author":"Fried","year":"2004","journal-title":"Drug Saf"},{"key":"2023042408274943300_R30","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM200104123441504","article-title":"The teratogenicity of anticonvulsant drugs","volume":"344","author":"Holmes","year":"2001","journal-title":"N Engl J Med"},{"key":"2023042408274943300_R31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1528-1157.1980.tb04320.x","article-title":"Multi-institutional study on the teratogenicity and fetal toxicity of anti-epileptic drugs","volume":"21","author":"Nakane","year":"1980","journal-title":"Epilepsia"},{"key":"2023042408274943300_R32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1531-8249(199911)46:5<739::AID-ANA9>3.0.CO;2-2","article-title":"Anti-epileptic drug regimes and major congenital abnormalities in the offspring","volume":"46","author":"Samren","year":"1999","journal-title":"Ann Neurol"},{"key":"2023042408274943300_R33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3476(75)80604-4","article-title":"The fetal hydantoin syndrome","volume":"87","author":"Hanson","year":"1975","journal-title":"J Pediatr"},{"key":"2023042408274943300_R34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajmg.1320190308","article-title":"The fetal valproate syndrome","volume":"19","author":"DiLiberti","year":"1984","journal-title":"Am J Med Genet"},{"key":"2023042408274943300_R35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1212\/WNL.59.4.630","article-title":"Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility","volume":"59","author":"Malm","year":"2002","journal-title":"Neurology"},{"key":"2023042408274943300_R36","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.1997.tb01480.x","article-title":"Maternal use of antiepileptic drugs and the risk of major congenital malformations","volume":"38","author":"Samren","year":"1997","journal-title":"Epilepsia"},{"key":"2023042408274943300_R37","first-page":"57","article-title":"The safety of antiepileptic drugs in pregnancy: results of the UK epilepsy and pregnancy register. (Abstract)","volume":"45","author":"Morrow","year":"2004","journal-title":"Epilepsia"},{"key":"2023042408274943300_R38","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S1059-1311(02)00135-8","article-title":"Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate","volume":"11","author":"Mawer","year":"2002","journal-title":"Seizure"},{"key":"2023042408274943300_R39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0920-1211(98)00084-9","article-title":"Congenital malformations due to antiepileptic drugs","volume":"33","author":"Kaneko","year":"1999","journal-title":"Epilepsy Res"},{"key":"2023042408274943300_R40","first-page":"S35","article-title":"The risk of spina bifida aperta after first trimester exposure to valproate in a prenatal cohort","volume":"42","author":"Omtzigt","year":"1992","journal-title":"Neurology"},{"key":"2023042408274943300_R41","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/0024-3205(81)90541-5","article-title":"A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant rate administration in the mouse using human drug and metabolite concentrations","volume":"29","author":"Nau","year":"1981","journal-title":"J Life Sci"},{"key":"2023042408274943300_R42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jnnp.70.1.15","article-title":"Additional educational needs in children born to mothers with epilepsy","volume":"70","author":"Adab","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042408274943300_R43","first-page":"296","article-title":"Effect of antiepileptic drugs on psychomotor development in offspring of epileptic mothers. (Abstract)","volume":"40","author":"Ohtsuka","year":"1999","journal-title":"Epilepsia"},{"key":"2023042408274943300_R44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1212\/WNL.62.1.28","article-title":"Normal intelligence in children with prenatal exposure to carbamazepine","volume":"62","author":"Gaily","year":"2004","journal-title":"Neurology"},{"key":"2023042408274943300_R45","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/jnnp.2003.029132","article-title":"The longer term outcome of children born to mothers with epilepsy","volume":"75","author":"Adab","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042408274943300_R46","first-page":"57","article-title":"The effects of antiepileptic drug exposure in utero to neurological and cognitive functioning of children of school age. (Abstract)","volume":"45","author":"Eriksonn","year":"2004","journal-title":"Epilepsia"},{"key":"2023042408274943300_R47","volume-title":"Cochrane Library.","author":"Adab","year":"2004"},{"key":"2023042408274943300_R48","first-page":"6","article-title":"Sodium valproate and prescribing in pregnancy","volume":"29","author":"Committee on the Safety of Medicines","year":"2003","journal-title":"Current Problems in Pharmacovigilance"},{"key":"2023042408274943300_R49","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bmj.321.7262.674","article-title":"Population based, prospective study of the care of women with epilepsy in pregnancy","volume":"321","author":"Fairgrieve","year":"2000","journal-title":"BMJ"},{"key":"2023042408274943300_R50","first-page":"57","article-title":"Eleven year interim results of an international study of pregnancy outcomes following exposure to lamotrigine. (Abstract)","volume":"45","author":"Weil","year":"2004","journal-title":"Epilepsia"},{"key":"2023042408274943300_R51","first-page":"132","article-title":"Prevention of neural tube defects; results of the Medical Research Council vitamin study","volume":"338","author":"MRC Vitamin Study Research Group","year":"1991","journal-title":"Lancet"},{"key":"2023042408274943300_R52","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJM199212243272602","article-title":"Prevention of the first occurrence of neural tube defects by periconceptual multivitamin supplementation","volume":"327","author":"Czeizel","year":"1992","journal-title":"N Engl J Med"},{"key":"2023042408274943300_R53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0028-2243(84)90119-9","article-title":"Effect of folic acid supplementation on congenital malformations due to anticonvulsant drugs","volume":"18","author":"Biale","year":"1984","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023042408274943300_R54","first-page":"305","article-title":"Red cell folate levels in pregnant epileptic women","volume":"48","author":"Tomson","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"2023042408274943300_R55","first-page":"703","article-title":"Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects","volume":"86","author":"Kirke","year":"1993","journal-title":"Q J Med"},{"key":"2023042408274943300_R56","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1701-2163(16)30248-1","article-title":"The use of folic acid for the prevention of neural tube defects and other congenital anomalies","volume":"25","author":"Genetics Committee, Executive and Council of the Society of Obstetricians and Gynaecologists of Canada","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"key":"2023042408274943300_R57","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199911113412001","article-title":"Prevention of neural tube defects with folic acid in China","volume":"341","author":"Berry","year":"1999","journal-title":"N Engl J Med"},{"key":"2023042408274943300_R58","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(83)92654-5","article-title":"Further experience of vitamin supplementation for prevention of neural tube defect recurrences","volume":"i","author":"Smithells","year":"1983","journal-title":"Lancet"},{"key":"2023042408274943300_R59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/bmj.328.7433.211","volume":"328","author":"Lucock","year":"2004","journal-title":"BMJ"},{"key":"2023042408274943300_R60","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/ajcn\/65.6.1790","article-title":"Unmetabolised folic acid in serum","volume":"65","author":"Kelly","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"2023042408274943300_R61","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0140-6736(01)07104-5","article-title":"Quantifying the effect of folic acid","volume":"358","author":"Wald","year":"2001","journal-title":"Lancet"},{"key":"2023042408274943300_R62","first-page":"457","volume-title":"British national formulary","author":"BMA\/Royal Pharmaceutical Society of Great Britain","year":"2004"},{"key":"2023042408274943300_R63","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/tera.1420520506","article-title":"Lack of attenuation of valproate induced effects by folinic acid in rat embryos in vitro","volume":"52","author":"Hansen","year":"1995","journal-title":"Teratology"},{"key":"2023042408274943300_R64","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1212\/WNL.61.6_suppl_2.S23","article-title":"Management issues for women with epilepsy: neural tube defects and folic acid supplementation","volume":"61","author":"Yerby","year":"2003","journal-title":"Neurology"},{"key":"2023042408274943300_R65","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/bmj.317.7160.694","article-title":"First trimester ultrasound screening","volume":"317","author":"McFayden","year":"1998","journal-title":"BMJ"},{"key":"2023042408274943300_R66","first-page":"77","volume-title":"Maternal epilepsy and pregnancy outcome.","author":"Samren","year":"1998"},{"key":"2023042408274943300_R67","first-page":"85","article-title":"Trimestral changes of seizure frequency in pregnant epileptic women","volume":"48","author":"Vidovic","year":"1994","journal-title":"Acta Med Croatica"},{"key":"2023042408274943300_R68","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1212\/WNL.61.6_suppl_2.S35","article-title":"Antiepileptic drug pharmacokinetics during pregnancy and lactation","volume":"61","author":"Pennell","year":"2003","journal-title":"Neurology"},{"key":"2023042408274943300_R69","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1212\/WNL.59.2.251","article-title":"Lamotrigine clearance during pregnancy","volume":"59","author":"Tran","year":"2002","journal-title":"Neurology"},{"key":"2023042408274943300_R70","first-page":"234","article-title":"Lamotrigine clearance markedly increases during pregnancy. (Abstract)","volume":"43","author":"Pennell","year":"2002","journal-title":"Epilepsia"},{"key":"2023042408274943300_R70A","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/01.WNL.0000133213.10244.FD","article-title":"Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study","volume":"63","author":"de Haan","year":"2004","journal-title":"Neurology"},{"key":"2023042408274943300_R71","volume-title":"Use of lamotrigine monotherapy in women who are pregnant: is dose escalation needed during pregnancy? ILEA meeting","author":"Betts","year":"2001"},{"key":"2023042408274943300_R72","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00007691-199908000-00098","article-title":"The distribution of lamotrigine throughout pregnancy. (Abstract)","volume":"21","author":"Berry","year":"1999","journal-title":"Ther Drug Monit"},{"key":"2023042408274943300_R73","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1528-1157.2000.tb00232.x","article-title":"Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate and during lactation","volume":"41","author":"Ohman","year":"2000","journal-title":"Epilepsia"},{"key":"2023042408274943300_R74","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199905203402008","article-title":"Patients with refractory seizures","volume":"340","author":"Devinsky","year":"1999","journal-title":"N Engl J Med"},{"key":"2023042408274943300_R75","first-page":"47","volume-title":"Non-epileptic seizures","author":"Ramsey","year":"1993"},{"key":"2023042408274943300_R76","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ajog.2003.09.020","article-title":"Epilepsy and pregnancy: an obstetric perspective","volume":"190","author":"Richmond","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"2023042408274943300_R77","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1059-1311(02)00288-1","article-title":"Primary generalised epilepsy; a risk factor for seizures in labour and delivery","volume":"12","author":"Katz","year":"2003","journal-title":"Seizure"},{"key":"2023042408274943300_R78","first-page":"53","volume-title":"Epilepsy, pregnancy and the child","author":"Terramo","year":"1982"},{"key":"2023042408274943300_R79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0038-1647631","article-title":"Placental transfer of vitamin K1 and its implications in fetal haemostasis","volume":"60","author":"Manderbrot","year":"1988","journal-title":"Thromb Haemost"},{"key":"2023042408274943300_R80","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(95)90227-9","article-title":"Vitamin K","volume":"345","author":"Shearer","year":"1995","journal-title":"Lancet"},{"key":"2023042408274943300_R81","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/adc.70.3.248","article-title":"Vitamin K prophylaxis in the newborn","volume":"70","author":"Rennie","year":"1994","journal-title":"Arch Dis Child"},{"key":"2023042408274943300_R82","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/bmj.316.7126.230","article-title":"Preventing late bleeding in infants with vitamin K deficiency","volume":"316","author":"Tin","year":"1998","journal-title":"BMJ"},{"key":"2023042408274943300_R83","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/bmj.305.6849.341","article-title":"Childhood cancer, intramuscular vitamin K and pethidine given during labour","volume":"305","author":"Golding","year":"1992","journal-title":"BMJ"},{"key":"2023042408274943300_R84","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/bmj.316.7126.173","article-title":"Case control study of childhood leukaemia and cancer in Scotland: findings for neonatal intramuscular vitamin K","volume":"316","author":"McKinney","year":"1998","journal-title":"BMJ"},{"key":"2023042408274943300_R85","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/bmj.316.7126.178","article-title":"Case control studies of relation between childhood cancer and neonatal vitamin K administration","volume":"316","author":"Passmore","year":"1998","journal-title":"BMJ"},{"key":"2023042408274943300_R86","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/bmj.316.7126.184","article-title":"Ecological studies of relation between hospital policies on neonatal vitamin K administration and subsequent occurrence of childhood cancer","volume":"316","author":"Passmore","year":"1998","journal-title":"BMJ"},{"key":"2023042408274943300_R87","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/bmj.316.7126.189","article-title":"Neonatal vitamin K administration and childhood cancer in the north of England","volume":"316","author":"Parker","year":"1998","journal-title":"BMJ"},{"key":"2023042408274943300_R88","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0140-6736(01)06959-8","article-title":"Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case control study","volume":"358","author":"Thompson","year":"2001","journal-title":"Lancet"},{"key":"2023042408274943300_R89","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1212\/WNL.58.4.549","article-title":"Enzyme inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate","volume":"58","author":"Kaaja","year":"2002","journal-title":"Neurology"},{"key":"2023042408274943300_R90","first-page":"500","volume-title":"Antiepileptic drugs","author":"Anderson","year":"2002","edition":"5th"},{"key":"2023042408274943300_R91","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1046\/j.1528-1157.2002.12502.x","article-title":"Topiramate kinetics during delivery, lactation and in the neonate","volume":"43","author":"Ohman","year":"2002","journal-title":"Epilepsia"},{"key":"2023042408274943300_R92","first-page":"58","article-title":"Levetiracetam in pregnancy and lactation. (Abstract)","volume":"45","author":"Johannessen","year":"2004","journal-title":"Epilepsia"},{"key":"2023042408274943300_R93","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/seiz.1999.0325","article-title":"Proactive preconceptual counselling for women with epilepsy","volume":"8","author":"Betts","year":"1999","journal-title":"Seizure"},{"key":"2023042408274943300_R94","first-page":"185","volume-title":"Practical genetic counselling","author":"Harper","year":"2004","edition":"6th"},{"key":"2023042408274943300_R95","first-page":"81","volume-title":"The treatment of epilepsy","author":"Nashef","year":"1996"},{"key":"2023042408274943300_R96","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1059-1311(97)80049-0","article-title":"Managing the teenager with epilepsy: paediatric to adult care","volume":"6","author":"Appleton","year":"1997","journal-title":"Seizure"},{"key":"2023042408274943300_R97","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0140-6736(01)06353-X","article-title":"Effects of framing on teratogenic risk perception in pregnant women","volume":"358","author":"Jasper","year":"2001","journal-title":"Lancet"},{"key":"2023042408274943300_R98","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.61.6_suppl_2.S2","article-title":"Catamenial epilepsy","volume":"61","author":"Foldary-Schaefer","year":"2003","journal-title":"Neurology"},{"key":"2023042408274943300_R99","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1528-1157.1998.tb02602.x","article-title":"Hormonal effects on epilepsy in women","volume":"39","author":"Klein","year":"1998","journal-title":"Epilepsia"},{"key":"2023042408274943300_R100","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/jnnp.47.12.1279","article-title":"Intermittent clobazam for catamenial epilepsy","volume":"47","author":"Feely","year":"1984","journal-title":"J Neurol Neurogurg Psychiatry"},{"key":"2023042408274943300_R101","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1212\/01.WNL.0000081228.48016.44","article-title":"Seizure frequency is associated with age at menopause in women with epilepsy","volume":"61","author":"Harden","year":"2003","journal-title":"Neurology"},{"key":"2023042408274943300_R102","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1528-1157.1999.tb02012.x","article-title":"The effect of menopause and perimenopause on the course of epilepsy","volume":"40","author":"Harden","year":"1999","journal-title":"Epilepsia"},{"key":"2023042408274943300_R103","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1528-1157.2002.15801.x","article-title":"Risk of extremity fractures in adult outpatients with epilepsy","volume":"43","author":"Persson","year":"2002","journal-title":"Epilepsia"},{"key":"2023042408274943300_R104","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.61.6_suppl_2.S16","article-title":"The menopause and bone density issues for women with epilepsy","volume":"61","author":"Harden","year":"2003","journal-title":"Neurology"},{"key":"2023042408274943300_R105","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.yebeh.2003.11.028","article-title":"Treatment of anticonvulsant drug-induced bone disease","volume":"5","author":"Drezner","year":"2004","journal-title":"Epilepsy Behav"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/81\/955\/278\/50025430\/postgradmedj-81-278.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/81\/955\/278\/50025430\/postgradmedj-81-278.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:32:32Z","timestamp":1682325152000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/81\/955\/278\/7031889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":106,"journal-issue":{"issue":"955","published-online":{"date-parts":[[2005,5,5]]},"published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2004.030221","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,5]]},"published":{"date-parts":[[2005,5,1]]}}}